Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis.

Chisato Saeki,Tomoya Kanai,Kaoru Ueda,Masanori Nakano,Tsunekazu Oikawa,Yuichi Torisu,Masayuki Saruta,Akihito Tsubota

Frontiers in medicine（2023）

引用 0|浏览1

暂无评分

摘要

Low serum IGF-1 levels were significantly and independently associated with decompensation development and poor long-term prognosis in patients with compensated cirrhosis. Therefore, IGF-1 may be useful for predicting decompensation-related events and should be regularly monitored in the management of compensated phase.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要